Rocket Pharmaceuticals, Inc. Fair Value Adjustment of Warrants
Rocket Pharmaceuticals, Inc. (RCKT) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-02-26
- Rocket Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $0.00.
- Rocket Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $0.00.
- Rocket Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was $0.00.
- Rocket Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Rocket Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2025 was $0.00.
- Rocket Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2024 was -$1.88M.
- Rocket Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2023 was -$364.00K.
- Rocket Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2015 was -$267.00K, a 131.60% decline from fiscal 2014.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | -$1.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | -$1.00K derived: sum of 3 quarters · filed 2026-02-26 | -$105.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | -$1.00K derived: sum of 2 quarters · filed 2026-02-26 | -$105.00K derived: sum of 3 quarters · filed 2026-02-26 | -$2.99M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$105.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.99M derived: sum of 3 quarters · filed 2026-02-26 | -$1.88M 10-K · filed 2026-02-26 | $1.88M 10-K · filed 2025-02-27 |
| 2024-09-30 | -$104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.99M derived: sum of 2 quarters · filed 2025-11-06 | -$1.88M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.77M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $1.11M 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | -$364.00K 10-K · filed 2025-02-27 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | -$267.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | -$267.00K 10-Q · filed 2016-11-09 | -$78.00K derived: sum of 4 quarters · filed 2016-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$267.00K 10-Q · filed 2016-08-10 | -$78.00K derived: sum of 3 quarters · filed 2016-08-10 | -$20.00K derived: sum of 4 quarters · filed 2016-08-10 | |
| 2015-03-31 | -$267.00K 10-Q · filed 2016-05-11 | -$78.00K derived: sum of 2 quarters · filed 2016-05-11 | -$20.00K derived: sum of 3 quarters · filed 2016-05-11 | $385.00K derived: sum of 4 quarters · filed 2016-05-11 | |
| 2014-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $247.00K derived: sum of 2 quarters · filed 2016-03-23 | $652.00K derived: sum of 3 quarters · filed 2016-03-23 | $845.00K 10-K · filed 2016-03-23 | |
| 2014-09-30 | $58.00K 10-Q · filed 2015-11-12 | $463.00K derived: sum of 2 quarters · filed 2015-11-12 | $656.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $405.00K 10-Q · filed 2015-08-07 | $598.00K 10-Q · filed 2015-08-07 | |||
| 2014-03-31 | $193.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |